As demonstrated by VERIFY study:

• Early combination treatment strategy of Galvus Met was superior to standard of care metformin monotherapy: Offers 2 extra years of glycemic control¹
• Hypoglycemia and adverse event were not significantly increased with early initiation of Galvus Met vs metformin monotherapy¹
• Endorsed by ADA 2020 Guideline: Early treatment combination therapy can be considered at treatment initiation to extend the time to treatment failure in some patients²

 
References:
1) Matthews DR et al. Lancet. 2019;394:1519-1529;
2) American Diabetes Association. (2020). 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.Diabetes Care,43(Supplement 1), S77-S88.
3) Prescribing information available at https://www.novartis.com.my/product-list-v2/products?sort_bef_combine=title+ASC&sort_bef_combine=title+ASC&combine=galvus+met